• 1
    Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (encephalopathy); diagnosis and management.
  • 2
    Rowe PC, Calkins H. Neurally mediated hypotension and chronic fatigue syndrome. Am J Med 1998; 105: 15S21S.
  • 3
    Schondorf R, Freeman R. The importance of orthostatic intolerance in the chronic fatigue syndrome. Am J Med Sci 1999; 317: 11723.
  • 4
    Schondorf R, Benoit J, Wein T, Phaneuf D. Orthostatic intolerance in the chronic fatigue syndrome. J Auton Nerv Syst 1999; 75: 192201.
  • 5
    Winkler AS, Blair D, Marsden JT, Peters TJ, Wessely S, Cleare AJ. Autonomic function and serum erythropoietin levels in chronic fatigue syndrome. J Psychosom Res 2004; 56: 17983.
  • 6
    Newton JL, Okonkwo O, Sutcliffe K, Seth A, Shin J, Jones DEJ. Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM 2007; 100: 51926.
  • 7
    Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997; 102: 35764.
  • 8
    Karas B, Grubb BP, Boehm K et al. The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. PACE 2000; 23: 34451.
  • 9
    LaManca JJ, Peckerman A, Walker J et al. Cardiovascular response during head-up tilt in chronic fatigue syndrome. Clin Physiol 1999; 19: 11120.
  • 10
    De Becker P, Dendale P, De Meirleir K, Campine I, Vandenborne K, Hagers Y. Autonomic testing in patients with chronic fatigue syndrome. Am J Med 1998; 105: 22S6S.
  • 11
    Yoshiuchi K, Quigley KS, Ohashi K, Yamamoto Y, Natelson BH. Use of time-frequency analysis to investigate temporal patterns of cardiac autonomic response during head-up tilt in chronic fatigue syndrome. Auton Neurosci 2004; 113: 5562.
  • 12
    Yamamoto Y, LaManca JJ, Natelson BH. A measure of heart rate variability is sensitive to orthostatic challenge in women with chronic fatigue syndrome. Exp Biol Med 2003; 228: 16774.
  • 13
    Pagani M, Lucini D. Chronic fatigue syndrome: a hypothesis focusing on the autonomic nervous system. Clin Sci 1999; 96: 11725.
  • 14
    Stewart J, Weldon A, Arlievsky N et al. Neurally mediated hypotension and autonomic dysfunction measured by heart rate variability during head-up tilt testing in children with chronic fatigue syndrome. Clin Autonom Res 1998; 8: 22130.
  • 15
    Timmers HJ, Wieling W, Soetekouw PM, Bleijenberg G, Van Der Meer JW, Lenders JW. Hemodynamic and neurohumoral responses to head-up tilt in patients with chronic fatigue syndrome. Clin Auton Res 2002; 12: 27380.
  • 16
    Peckerman A, La Manca JJ, Krishna KA et al. Abnormal impedance cardiography predicts symptom severity in chronic fatigue syndrome. Am J Med Sci 2003; 326: 5560.
  • 17
    Stewart JM. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000; 48: 21826.
  • 18
    Amann M, Dempsey JA. Locomotor muscle fatigue modifies central motor drive in healthy humans and imposes limitation to exercise performance. J Physiol 2008; 586: 16173.
  • 19
    Hollingsworth KG, Newton JL, Taylor R et al. Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis. CGH 2008; 6: 10418.
  • 20
    Paul L, Wood L, Behan WMH, Maclaren WM. Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. Eur J Neurol 1999; 6: 639.
  • 21
    Juel C. Muscle pH regulation: role of training. Acta Physiol Scand 1998; 162: 35966.
  • 22
    Mainwood GW, Alward M. Evidence of extracellular mechanism for the action of H+ on recovery of muscles following fatigue. Can J Physiol Pharmacol 1982; 60: 17204.
  • 23
    Fukuda K, Straus SE, Hickie I et al. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 1994; 121: 9539.
  • 24
    Berstein MS, Morabia A, Sloutski D. Definition and prevalence of sedentarism in an urban population. Am J Public Health 1999; 89: 8627.
  • 25
    Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18(Suppl 1): S7983.
  • 26
    Kos D, Nagels G, D’Hooghe MB, Duportail M, Kerckhofs E. A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurol 2006; 6: 27.
  • 27
    Boska M. ATP production rates as a function of force level in the human gastrocnemius/soleus using 31P MRS. Magn Res Med 1994; 32: 110.
  • 28
    Vanhamme L, Van DenBoogaart A, Van Huffel SImproved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129: 3543.
  • 29
    Kemp GJ, Radda GK. Quantitative interpretation of bioenergetic data from 31P and 1H magnetic resonance spectroscopic muscle: an analytical review. Magn Reson Quart 1994; 10: 4363.
  • 30
    Anonymous. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task force of the European society of cardiology and the North American society of pacing and electrophysiology. Circulation 1996; 93: 104365.
  • 31
    Kemp GJ, Thompson CH, Taylor DJ, Radda GK. Proton efflux in human skeletal muscle during recovery from exercise. Eur J Appl Physiol 1997; 76: 46271.
  • 32
    Kemp GJ, Roberts N, Bimson WE et al. Mitochondrial function and oxygen supply in normal and chronically ischaemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo. J Vasc Surg 2001; 34: 110310.
  • 33
    Syme PD, Brunotte F, Green Y, Aronson JK, Radda GK. The effect of beta 2-adrenoceptor stimulation and blockade of L-type calcium channels on in vivo Na+/H+ antiporter activity in rat skeletal muscle. Biochim Biophys Acta 1991; 1093: 23440.
  • 34
    Lane RJM, Barrett MC, Taylor DJ, Kemp GJ, Lodi R. Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle. Neuro Disord 1998; 8: 2049.
  • 35
    Wong R, Lopaschuk G, Zhu G et al. Skeletal muscle metabolism in the chronic fatigue syndrome. Chest 1992; 102: 171622.
  • 36
    McCully KK, Smith S, Rajaei S, Leigh Jr JS, Natelson BH. Blood flow and muscle metabolism in the chronic fatigue syndrome. Clin Sci (Lond) 2003; 104: 6417.
  • 37
    Barnes PRJ, Taylor DJ, Kemp GJ, Radda GK. Skeletal muscle bioenergetics in the chronic fatigue syndrome. JNNP 1993; 56: 67983.
  • 38
    Nijs J, Paul L, Wallman K. Chronic fatigue syndrome: an approach combining self-management with graded exercise to avoid exacerbations. J Rehab Med 2008; 40: 2417.